CHC Healthcare Group (TPE:4164)
Taiwan · Delayed Price · Currency is TWD 33.45
+0.45 (1.36%)
Feb 11, 2026, 1:30 PM CST
CHC Healthcare Group Market Cap
CHC Healthcare Group has a market cap or net worth of 6.53 billion as of February 13, 2026. Its market cap has decreased by -8.94% in one year.
Market Cap
6.53B
Enterprise Value
10.28B
Revenue
4.21B
Ranking
n/a
PE Ratio
37.22
Stock Price
33.45
Market Cap Chart
Since October 18, 2011, CHC Healthcare Group's market cap has decreased from 9.89B to 6.53B, a decrease of -33.95%. That is a compound annual growth rate of -2.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 6.53B | -13.12% |
| Dec 31, 2025 | 7.52B | 7.82% |
| Dec 31, 2024 | 6.97B | -31.26% |
| Dec 29, 2023 | 10.15B | 44.21% |
| Dec 30, 2022 | 7.04B | 14.81% |
| Dec 30, 2021 | 6.13B | 3.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 269.25B |
| Caliway Biopharmaceuticals | 231.72B |
| Lotus Pharmaceutical | 85.34B |
| Heron Neutron Medical | 69.79B |
| Formosa Laboratories | 6.91B |
| Mycenax Biotech | 6.85B |
| Orient Pharma | 6.46B |
| SCI Pharmtech | 6.35B |